Breakthrough in Cell Signaling May Enable Smarter Cancer Drug Design
University of Haifa scientists, led by Prof. Hila Toledano, discovered a Notch receptor 'reverse signaling' mechanism, potentially revolutionizing cancer drug.
University of Haifa scientists, led by Prof. Hila Toledano, discovered a Notch receptor 'reverse signaling' mechanism, potentially revolutionizing cancer drug.
Researchers at Hebrew University in Jerusalem created EvORanker, an AI tool that rapidly identifies rare disease genes, led by Dr. Christina Canavati and Prof.
Israeli and U.S. scientists (Profs. Goldberg, Plotkin) found brain cells over-activate serotonin, explaining OCD and depression.